# Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.

> **NCT03211325** · NA · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 29 (actual)

## Conditions studied

- Raynaud's Phenomenon Isolated Primary
- Raynaud's Phenomenon (Secondary)
- Healthy

## Interventions

- **PROCEDURE:** Biopsy

## Key facts

- **NCT ID:** NCT03211325
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-18
- **Primary completion:** 2019-03-17
- **Final completion:** 2019-06-27
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211325, "Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03211325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*